Topical pimecrolimus 1% for the treatment of pruritic external auditory canals

Laryngoscope

Volumn 116, Issue 10, 2006, Pages 1809-1812

  Djalilian, Hamid R ^a   Memar, Omid ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Academic Dermatology and Skin Cancer Institute   (United States)

Author keywords

Calcineurin inhibitor; Contact dermatitis; Ears; Pimecrolimus; Pruritis

Indexed keywords

ACETIC ACID; DOXEPIN; PIMECROLIMUS;

ABSENCE OF SIDE EFFECTS; CERUMEN; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; EXTERNAL OTITIS; FEMALE; FOLLOW UP; HUMAN; MALE; PRIORITY JOURNAL; PRURITUS; RETROSPECTIVE STUDY; REVIEW; STATISTICAL SIGNIFICANCE; SYMPTOM;

ADMINISTRATION, TOPICAL; CALCINEURIN; CERUMEN; COHORT STUDIES; DERMATOLOGIC AGENTS; EAR CANAL; EAR DISEASES; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; OINTMENTS; PRURITUS; RETROSPECTIVE STUDIES; TACROLIMUS;

EID: 33749432168     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mlg.0000231562.83733.53     Document Type: Review

References (10)

1. Kolbe L, Kligman AM, Schreiner V, et al. Corticosteroid-induced atrophy and barrier impairment measured by non-invasive methods in human skin. Skin Res Technol 2001;7:73-77.
2. Meurer M, Fartasch M, Albrecht G, et al. Long-term efficacy and safety of pimecrolimus cream 1% in adults with moderate atopic dermatitis. Dermatology 2004;208:365-372.
3. Amrol D, Keitel D, Hagaman D, et al. Topical pimecrolimus in the treatment of human allergic contact dermatitis. Ann Allergy Asthma Immunol 2003;91:563-566.
4. Derebery J, Berliner KI. Foot and ear disease-the dermatophytid reaction in otology. Laryngoscope 1996;106:181-186.
5. Mabry RL. Treatment of itching ears with fluocinolone acetonide. Eye Ear Nose Throat Mon 1974;53:333-334.
6. Li LY, Cruz PD Jr. Allergic contact dermatitis: pathophysiology applied to future therapy. Dermatol Ther 2004;17:219-223.
7. Cohen DE. Contact dermatitis: a quarter century perspective. J Am Acad Dermatol 2004;51:60-63.
8. Seftel DM. Itching in the ear canal due to hypocerumenosis. An effective method of treatment. Calif Med 1963;98:151-152.
9. Billich A, Aschauer H, Aszodi A, et al. Percutaneous absorption of drugs used in atopic eczema: pimecrolimus permeates less through skin than corticosteroids and tacrolimus. Int J Pharm 2004;9:269:29-35.
10. Ring J, Barker J, Behrendt H, et al. Review of the potential photo-cocarcinogenicity of topical calcineurin inhibitors: position statement of the European Dermatology Forum. J Eur Acad Dermatol Venereol 2005;19:663-671.